Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      30 trials found for solid tumor

      Recruiting
      Not yet recruiting
      Recruiting
      NCT06466187
      A Study of SGN-MesoC2 in Advanced Solid Tumors

      Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Adenocarcinoma, Colorectal Neoplasms, Mesothelioma, Other Solid Tumors, Endometrial

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT06120504
      A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers

      Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin

      Male or Female
      18+ years
      28study location(s)
      Recruiting
      NCT04389632
      A Study of Sigvotatug Vedotin in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      131study location(s)
      Recruiting
      NCT05756569
      Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

      Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Neoplasm, Malignant Ureter Neoplasm, Malignant Urethral Neoplasm, Metastatic Bladder Carcinoma, Stage III Bladder Cancer AJCC v8, Stage IV Bladder

      Male or Female
      18+ years
      4study location(s)
      Recruiting
      NCT05896163
      A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

      Diffuse Large B-Cell Lymphoma

      Male or Female
      18+ years
      27study location(s)
      Recruiting
      NCT06487078
      Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

      ALK+ Non-Small-Cell Lung Carcinoma

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT05226871
      Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

      Breast Cancer, Head and Neck Cancer

      Male or Female
      18+ years
      22study location(s)
      Recruiting
      NCT04557449
      Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

      Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

      Male or Female
      18+ years
      38study location(s)
      Aug 22, 2025 - Planned start date (Not yet recruiting)
      NCT07144280
      A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

      Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma

      Male or Female
      18+ years
      Aug 07, 2025 - Planned start date (Not yet recruiting)
      NCT07090499
      A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

      Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non Small Cell Lung, Carcinoma, Squamous Cell of Head and Neck, Head and Neck Cancer, Esophageal Cancer,

      Male or Female
      18+ years

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.